Home > News > BioTrove, Inc. Completed a $13.7 Million Round of Financing
April 15th, 2004
BioTrove, Inc. Completed a $13.7 Million Round of Financing
Abstract:
BioTrove, Inc. today announced that the Company has successfully completed a $13.7 million round of
financing, closing a second traunch of an oversubscribed round for $2.8 million. The first traunch closed at $10.9 million. Catalyst Health and Technology Partners led the round, supported by new investors Echelon Ventures
and Fletcher Spaght. Original investors from the first traunch include CB Health Ventures, Zero Stage Capital and BioFrontier Partners.
Source:
PRNewswire
Bookmark:
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013